UK's largest collection of tissue, cells and blood samples from #mesothelioma patients. We provide samples to several #research institutions around the world.
Happening now, Niki Veale presents the first talk at the "What's New in Thoracic Cancer?" seminar.
Niki Veale, Tim Halim, and Ekpemi Irune present ongoing work in thoracic cancers of unmet need.
@TheCIMR @Prof_Marciniak
@CRUKCamCentre@CUH_NHS@CRUK_CI
On Monday 24 June at 6pm GMT, we'll hold an event for #WorldPneumothoraxDay.
Our speakers will talk about the latest information relating to pneumothorax & BHD. We'll also host a Q&A session, to give you the opportunity to ask the experts!
Register here: https://t.co/cQkHoWCCV0
Excited to be hosting this event with @Prof_Marciniak and Prof Simon Johnson for our World Pneumothorax Day webinar on 24th June 2024! #PatientAdvocacy#Pneumothorax
Wishing the best of luck to our Chair of Trustees, Nick Maskell, who's taking on a remarkable challenge, trying to cycle further in one day then he has ever achieved before - 140 miles and 5km of vertical height - at the Mallorca 312 on Saturday 27 April.
Rare disease research at Cambridge has received a major boost from charity @LifeArc1.
Our researchers such as @Prof_Marciniak will play leading roles in the LifeArc Centres for Rare Mitochondrial Diseases and Rare Respiratory Diseases.
@cam_mito
https://t.co/oKiu0lpFR8
After many years, and a pandemic in between, it is great to see this work from @XiewenLiu published at @ChemMater. We use our #MOFs to develop new therapies for one of the most difficult #cancer indications, #mesothelioma. We show slow drug release using new coatings and ...
Asbestos exposure can lead to a number of lung conditions including mesothelioma. We are proud to fund over £12 million of mesothelioma research to better understand and treat this cancer. #GlobalAsbestosAwarenessWeek
A collaboration between @Prof_Marciniak lab, @rintoul_robert and Mathew Garnett @sangerinstitute has resulted in the first comprehensive single-cell transcriptomic atlas of the human parietal pleura
https://t.co/azRyOeF9im
.@QMUC and the ATOMIC-meso trial have found that arginine blocking pegargiminase based chemotherapy slows mesothelioma tumor development, increasing patient survival by 1.6 months - a welcome result for people living with this rare cancer.
https://t.co/ABGqbyTgyT
Supplied 60+ research groups
Provided data rich - longitudinal data
In doing so, we’ve supported multiple publications
We’ve funded 5 Mesobank research fellows who published impactful research
3/4
Congratulations to Fellow @Prof_Marciniak (2011) & @TheCIMR team on mapping cells in the human parietal pleura (membrane around lungs). Poor knowledge of these cells has hampered drug development for conditions, eg pleural mesothelioma: https://t.co/Jy51dW7Zck @ERSpublications
Finally out! The first ever single cell atlas of the human pleura! Everything you ever wanted to know about mesothelioma cells! Kudos to Dr. Joanna Obacz , Prof Marciniak and team!! see paper here https://t.co/r8BxvnPA1u and 🧵from the great @Prof_Marciniak 👇🏼
Interesting study if mesothelioma - fibroblast crosstalk
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells
https://t.co/pNLY1bjjM0
Last week to apply for a Postdoc position and a Laboratory Technician position for our group.
Come join us!!!
👇
https://t.co/whlOGEFik5
https://t.co/mjwGiv5Pwp